Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Linda Marban
Person

Linda Marban

Tracked across 2 events · 293 articles · First seen Jun 26, 2026 · Last active Aug 19, 2026

Sentiment
-40
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
6 -80
Regulatory
Capricor Deramiocel FDA Setback Securities Class Actions
Paragon Therapeutics, a biotechnology company developing Deramiocel for Duchenne muscular dystrophy, faced a major regulatory setback. On July 27, 2026, the FDA released briefing documents ahead of an advisory committee meeting, raising concerns about post-hoc…
Impact: CEO who made positive statements about Deramiocel; now named in securities fraud lawsuits.
Jul 27, 2026 · 287 articles
6 0
Regulatory
Capricor Deramiocel FDA Advisory Meeting
Impact: Linda Marban, CEO of Paragon Therapeutics, expressed confidence in the evidence supporting Deramiocel and emphasized the company's commitment to bringing the therapy to patients.
Jun 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Linda Marban live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.